Cargando…
Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment
SIMPLE SUMMARY: Currently, organoid research is having a growing impact in oncology. Tumor organoids, directly derived from patients’ specimens, can easily be expanded and cryopreserved. For that reason, they are becoming an indispensable ally in clinics for quicker diagnosis and prognosis of malign...
Autores principales: | Vivarelli, Silvia, Candido, Saverio, Caruso, Giuseppe, Falzone, Luca, Libra, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761978/ https://www.ncbi.nlm.nih.gov/pubmed/33291603 http://dx.doi.org/10.3390/cancers12123636 |
Ejemplares similares
-
YY1 Silencing Induces 5-Fluorouracil-Resistance and BCL2L15 Downregulation in Colorectal Cancer Cells: Diagnostic and Prognostic Relevance
por: Vivarelli, Silvia, et al.
Publicado: (2021) -
Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets
por: Vivarelli, Silvia, et al.
Publicado: (2020) -
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
por: Leone, Gian Marco, et al.
Publicado: (2023) -
In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity
por: Lavoro, Alessandro, et al.
Publicado: (2023) -
Gut Microbiota and Cancer: From Pathogenesis to Therapy
por: Vivarelli, Silvia, et al.
Publicado: (2019)